Evidence map›Paper›PMID 24163148›Full record

ArticleDiabetes2014

Pak3 promotes cell cycle exit and differentiation of β-cells in the embryonic pancreas and is necessary to maintain glucose homeostasis in adult mice.

Julie Piccand, Aline Meunier, Carole Merle, Zhengping Jia, Jean-Vianney Barnier, Gérard Gradwohl

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. β-Cell Maturation and Identity in Health and Disease.International journal of molecular sciences · 2019
    Review
  18. Article
  19. Article
  20. Single-cell Transcriptomic Analyses of Mouse Pancreatic Endocrine Cells.Journal of visualized experiments : JoVE · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Julie PiccandInstitut de Génétique et de Biologie Moléculaire et Cellulaire, Department of Development and Stem Cells, Institut National de la Santé et de la Recherche Médicale UMR 964, Centre National de Recherche Scientifique, UMR 964, Université de Strasbourg, Illkirch, France.
Aline Meunier
Carole Merle
Zhengping Jia
Jean-Vianney Barnier
Gérard Gradwohl
Inserm · FRSickKids Foundation · CAUniversité de Strasbourg · FRUniversité Paris-Sud · FR

Funding

Pancreatic endocrine development and regenerationU19DK072495 · NIDDK · HAGEDORN RESEARCH INSTITUTE · PI SERUP, PALLE · 2005 to 2009
$5.6M
NIDDK NIH HHS U19 DK072495NIDDK NIH HHS U19-DK-072495
6 · The paper itself

Abstract

The transcription factor neurogenin3 (Ngn3) triggers islet cell differentiation in the developing pancreas. However, little is known about the molecular mechanisms coupling cell cycle exit and differentiation in Ngn3(+) islet progenitors. We identified a novel effector of Ngn3 endocrinogenic function, the p21 protein-activated kinase Pak3, known to control neuronal differentiation and implicated in X-linked intellectual disability in humans. We show that Pak3 expression is initiated in Ngn3(+) endocrine progenitor cells and next maintained in maturing hormone-expressing cells during pancreas development as well as in adult islet cells. In Pak3-deficient embryos, the proliferation of Ngn3(+) progenitors and β-cells is transiently increased concomitantly with an upregulation of Ccnd1. β-Cell differentiation is impaired at E15.5 but resumes at later stages. Pak3-deficient mice do not develop overt diabetes but are glucose intolerant under high-fat diet (HFD). In the intestine, Pak3 is expressed in enteroendocrine cells but is not necessary for their differentiation. Our results indicate that Pak3 is a novel regulator of β-cell differentiation and function. Pak3 acts downstream of Ngn3 to promote cell cycle exit and differentiation in the embryo by a mechanism that might involve repression of Ccnd1. In the adult, Pak3 is required for the proper control of glucose homeostasis under challenging HFD.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsBlood GlucoseCell CycleCell DifferentiationCyclin D1Enteroendocrine CellsHomeostasisInsulin-Secreting CellsMiceMice, KnockoutNerve Tissue Proteinsp21-Activated KinasesPancreasBasic Helix-Loop-Helix ProteinsBlood GlucoseCcnd1 protein, mouseCyclin D1Nerve Tissue ProteinsNeurog3 protein, mousep21-Activated KinasesPak3 protein, mouse

Identifiers

PMID24163148
PMCPMC3968432
OpenAlexW2136075462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.